Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Debt Ratio (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Debt Ratio for 15 consecutive years, with 0.5 as the latest value for Q4 2024.

  • On a quarterly basis, Debt Ratio rose 42.15% to 0.5 in Q4 2024 year-over-year; TTM through Dec 2024 was 0.5, a 42.15% increase, with the full-year FY2024 number at 0.5, up 42.15% from a year prior.
  • Debt Ratio was 0.5 for Q4 2024 at Plus Therapeutics, up from 0.47 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.64 in Q1 2024 to a low of 0.23 in Q4 2022.
  • A 5-year average of 0.38 and a median of 0.33 in 2023 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: tumbled 64.39% in 2020, then soared 97.5% in 2024.
  • Plus Therapeutics' Debt Ratio stood at 0.52 in 2020, then tumbled by 47.87% to 0.27 in 2021, then fell by 17.16% to 0.23 in 2022, then soared by 54.48% to 0.35 in 2023, then skyrocketed by 42.15% to 0.5 in 2024.
  • Per Business Quant, the three most recent readings for PSTV's Debt Ratio are 0.5 (Q4 2024), 0.47 (Q3 2024), and 0.29 (Q2 2024).